Palifermin (Kepivance) - Important Safety Information from Biovitrum as approved by the Irish Medicines Board
19 April 2010
Important Safety Information communication from Biovitrum on the restriction of the therapeutic indication of Palifermin (Kepivance) and consequential changes to product information.
Important Safety Information - Palifermin (Kepivance)